Single-Cell Epigenomics of Pancreatic Islets

Mapping cell-type-specific chromatin accessibility and its role in diabetes genetic risk.

The pancreatic islet contains multiple interacting cell types (beta, alpha, delta, and others), each with distinct transcriptional programs and disease associations. My PhD work applied single-cell ATAC-seq to human islets to generate high-resolution maps of cell-type-specific chromatin accessibility, revealing regulatory programs active in each cell type and linking them to type 2 diabetes GWAS loci (Chiou* et al., 2021). This provided a framework for interpreting non-coding genetic variants in the context of islet cell-type identity.

Complementary work characterized how environmental and nutrient signals reshape the islet epigenome to control adaptive insulin secretion (Wortham et al., 2023), and examined how genetic variation at type 2 diabetes loci affects cell-type-specific regulatory activity across disease states (Wang* et al., 2023). The resulting resource, a catalog of islet cell-type regulatory elements annotated with disease-relevant variants, is widely used in the field for interpreting diabetes GWAS results.


Related: Type 1 Diabetes and the Exocrine Pancreas — companion project revealing acinar cell contributions to T1D genetic risk using the same single-cell epigenomic approach.

References

2023

  1. Nutrient regulation of the islet epigenome controls adaptive insulin secretion
    Wortham M, Liu F, Harrington AR, and 19 more authors, including Chiou J
    Journal of Clinical Investigation, 2023
  2. Integrating genetics with single-cell multiomic measurements across disease states identifies mechanisms of beta cell dysfunction in type 2 diabetes
    Wang G*Chiou J*, Zeng C, and 18 more authors
    *Equal contribution
    Nature Genetics, 2023

2021

  1. Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes risk
    Chiou J*, Zeng C*, Zhang C, and 17 more authors
    *Equal contribution
    Nature Genetics, 2021